rheumatology

News in brief: New COVID-19 vaccination approach for rituximab patients; In-person medical conferences resume for ASBMR; Global medical journals call for emergency action on climate crisis

New COVID-19 vaccination approach for rituximab patients Vaccination against COVID-19 for rheumatic disease patients taking anti-CD20 therapy such as rituximab can be informed by new findings on CD4+ T-helper-cell counts as an immune biomarker, according to German researchers. In a study published in Lancet Rheumatology they confirmed that patients taking B-cell-depleting therapies showed blunted or ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic